KROS
Keros Therapeutics Inc
11.60$
+0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 70.4% | -160.0% | -1,475.8% | -309.2% | -350.3% | -82,455.6% | -4,531.5% | 44.0% | |
| 1.5% | 4.4% | 11.1% | 1.9% | 3.4% | 539.7% | 34.6% | 0.6% | |
| 0.8% | 0.6% | 163.9% | 58.3% | 93.4% | 19,048.3% | 982.3% | 11.8% | |
| 2.8% | 28.5% | 236.6% | 58.5% | 93.5% | – | – | – | |
| 79.5% | -67.2% | 91.0% | -80.0% | 71.5% | -1,755.0% | -322.2% | -5.0% | |
| 2.2% | 2.7% | 11.8% | 5.1% | 6.2% | 1,631.8% | 54.4% | 0.6% | |
| -2.2% | -2.7% | -11.8% | -5.1% | -6.2% | -1,631.8% | -54.4% | -0.6% | |
| 115.1% | 0.1% | 11,960.5% | 142.0% | 601.5% | – | 0.0% | -153.7% | |
| – | – | -16.8% | – | – | – | – | – | |
| 114.6% | 0.1% | 11,841.8% | 142.0% | 601.5% | 118,513.9% | 11,037.2% | -155.1% | |
| 182.9% | -162.4% | 10,354.2% | -172.2% | 245.0% | 34,426.5% | 6,451.3% | -111.7% | |
| 68.3% | -162.7% | -1,487.5% | -314.3% | -356.5% | -84,087.4% | -4,585.9% | 43.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.